MarketPeel
Insider Trading Intelligence
DK

David Kirske

XFOR
CHIEF FINANCIAL OFFICER · X4 PHARMACEUTICALS, INC · CIK 0001276750
FILING MIX · LIFETIME67%/33%
BUYS
4
SELLS
2
TOTAL VALUE
$109.2K
COMPANIES
1
ACTIVE SINCE
Aug 2025
HOLDINGS NOW
167,750
AVG SELL PX
$4.28
TRADE KIND
SHOWING 6 / 6
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 5 pending
Forward-return performance of every backtestable P/S trade by David Kirske, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-9.22%
14d1+100.00%-6.91%
30d1+100.00%-11.29%-1.73%-9.56%-9.56%
60d1(1 pending)
90d1(1 pending)
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
XFOR · 167,750 shares · as of Jun 30, 2026
0388,192776,3851,164,5771,552,7692026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2026
2026
FLOW · 4 buys / 2 sellsCOVERAGE · 4 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
XFOR
X4 PHARMACEUTICALS, INC
SALE
Chief Financial Officer
8,543$4.26$36.4K167,750Jun 30, 2026Jul 1, 2026View →
XFOR
X4 PHARMACEUTICALS, INC
SALE
Chief Financial Officer
16,961$4.29$72.8K176,293May 12, 2026May 13, 2026View →
XFOR
X4 PHARMACEUTICALS, INC
PURCHASEGRANT
Stock grant
1,552,7691,552,769Oct 29, 2025Oct 31, 2025View →
XFOR
X4 PHARMACEUTICALS, INC
PURCHASEGRANT
Stock grant
193,254193,254Aug 14, 2025Aug 14, 2025View →
XFOR
X4 PHARMACEUTICALS, INC
PURCHASEGRANT
Stock grant
352,800352,800Aug 14, 2025Aug 14, 2025View →
XFOR
X4 PHARMACEUTICALS, INC
PURCHASEGRANT
Stock grant
1,073,2491,073,249Aug 12, 2025Aug 14, 2025View →
Other insiders · XFOR
Loading peer insiders…
About this filer
CIK 0001276750
ROLE
Chief Financial Officer
PRIMARY
XFOR
COMPANIES
1
ACTIVE SINCE
Aug 2025
MARKETPEEL · /INSIDER/0001276750DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback